Wacker Chemie (WCH) investor relations material

Executive summary

• Q2 2026 sales rose 7% year-over-year to €1.52 billion, with EBITDA up 85% to €211 million, driven by cost savings, operational improvements, and special effects from pension and Siltronic share sales.

• Net income reached €350 million, including €243 million from Siltronic-related effects, compared to a €19 million loss in Q2 2025.

• The PACE cost program contributed significantly to improved profitability, targeting over €300 million in savings by 2028.

• The company remains focused on competitiveness, cost discipline, and portfolio sharpening for future growth.

• Sustainability efforts recognized with the L'Oréal Energy Award for CO₂ reduction in silicon metal production.

Financial highlights

• EBITDA before pension effects increased 53% to €175 million year-over-year.

• Reported EBITDA was €211 million, including a €37 million non-cash pension effect.

• EPS increased to €6.86 from -€0.49 year-over-year.

• Shareholder equity at end of June was €4.18 billion; liquidity was €1.57 billion.

• Net financial debt reduced to €722 million from €1,139 million year-over-year.

Outlook and guidance

• Full-year EBITDA guidance raised to €625–750 million, reflecting Q2 performance and pension effects.

• FY 2026 sales expected to be mid-single-digit percentage higher year-over-year.

• Net financial debt forecasted at approximately €500 million by year-end.

• Capital expenditures for 2026 projected at €300 million; positive net cash flow expected significantly above 2025.

• Forecast remains subject to high uncertainty due to geopolitical risks and trade policy.